Khaytin I, Tapia IE, Beck SE. Auto-titrating CPAP for the treatment of obstructive sleep apnea in children: a good beginning. . 2020;16(10):1825–1826.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954011 | PMC |
| http://dx.doi.org/10.5664/jcsm.8726 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: The current standard treatment for obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP), is characterized by a low adherence rate due to various factors including circuit-dependent carbon dioxide (CO) rebreathing, which can exacerbated by disparate factors, such as low PAP, use of auto-titrating PAP or ramps. However, risk factors for rebreathing are often overlooked or poorly understood in clinical practice. Therefore, our objective was to evaluate the extent of rebreathing occurring with commonly used CPAP masks across varying PAPs, tidal volumes, and respiratory rates.
View Article and Find Full Text PDFEffectiveness of remote monitoring in improving CPAP compliance and the impact of preexisting organisation of standard care: a randomised controlled trial.
Sleep Breath
August 2024
Department of Pulmonary Medicine, Centre for Sleep Medicine, Amphia Hospital, Postbus 90158, 4800 RK, Breda, The Netherlands.
Unlabelled: PURPOSE : Continuous positive airway pressure (CPAP) is often the treatment of choice for obstructive sleep apnea (OSA). Short-term adherence and early perceived benefits are the best predictors of long-term adherence. The aim of this study was to determine the effect of telemonitoring in the first period of treatment with CPAP (auto-titrating PAP) on compliance and the long-term outcome.
View Article and Find Full Text PDFSleep well with home automation.
Respirology
November 2023
CIRUS Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia.
Continuous Positive Airway Pressure plus Mandibular Advancement Therapy (PAPMAT): study protocol for an adaptive randomised crossover trial comparing the benefits and costs of combining two established treatments for obstructive sleep apnoea.
Trials
July 2023
Respiratory Support and Sleep Centre, Royal Papworth Hospital, Cambridge, UK.
Background: Obstructive sleep apnoea (OSA) involves repeated breathing pauses during sleep due to upper airway obstruction. It causes excessive daytime sleepiness and has other health impacts. Continuous positive airway pressure (CPAP) therapy is effective first line treatment for moderate to severe OSA.
View Article and Find Full Text PDFAverage volume-assured pressure support for patients with obstructive sleep apnea with failed CPAP titration.
Sleep Sci
January 2022
University of Maryland School of Medicine, Medicine - Baltimore - Maryland - United States.
Objectives: Obstructive sleep apnea (OSA) is a common disease, often treated using continuous positive airway pressure (CPAP) therapy. In many cases, patients fail a CPAP titration study due to inadequate control of the apnea-hypopnea index (AHI, events/hour) or due to treatment-emergent central sleep apnea (TE-CSA). We report our experience using a mode of non-invasive ventilation for alternative treatment of these patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!